AAAAAA

   
Results: 1-9 |
Results: 9
Chapter 6. Recent advances in the science and treatment of atherosclerosis
Authors: Burnett, DA Davis, HR
Citation: Da. Burnett et Hr. Davis, Chapter 6. Recent advances in the science and treatment of atherosclerosis, ANNU REP M, 36, 2001, pp. 57-66
Unusual brain growth patterns in early life in patients with autistic disorder - An MRI study
Authors: Courchesne, E Karns, CM Davis, HR Ziccardi, R Carper, RA Tigue, ZD Chisum, HJ Moses, P Pierce, K Lord, C Lincoln, AJ Pizzo, S Schreibman, L Haas, RH Akshoomoff, NA Courchesne, RY
Citation: E. Courchesne et al., Unusual brain growth patterns in early life in patients with autistic disorder - An MRI study, NEUROLOGY, 57(2), 2001, pp. 245-254
The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs
Authors: Davis, HR Pula, KK Alton, KB Burrier, RE Watkins, RW
Citation: Hr. Davis et al., The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs, METABOLISM, 50(10), 2001, pp. 1234-1241
The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys
Authors: van Heek, M Compton, DS Davis, HR
Citation: M. Van Heek et al., The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys, EUR J PHARM, 415(1), 2001, pp. 79-84
Ezetimibe, a potent cholesterol absorption inhibitor, normalizes combined dyslipidemia in obese hyperinsulinemic hamsters
Authors: van Heek, M Austin, TM Farley, C Cook, JA Tetzloff, GG Davis, HR
Citation: M. Van Heek et al., Ezetimibe, a potent cholesterol absorption inhibitor, normalizes combined dyslipidemia in obese hyperinsulinemic hamsters, DIABETES, 50(6), 2001, pp. 1330-1335
Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function
Authors: van Heek, M Farley, C Compton, DS Hoos, L Davis, HR
Citation: M. Van Heek et al., Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function, BR J PHARM, 134(2), 2001, pp. 409-417
Milton Feder
Authors: Davis, HR
Citation: Hr. Davis, Milton Feder, PS, 33(3), 2000, pp. 659-659
Synthesis of 3-arylpropenyl, 3-arylpropynyl and 3-arylpropyl 2-azetidinones as cholesterol absorption inhibitors: Application of the palladium-catalyzed arylation of alkenes and alkynes
Authors: Rosenblum, SB Huynh, T Afonso, A Davis, HR
Citation: Sb. Rosenblum et al., Synthesis of 3-arylpropenyl, 3-arylpropynyl and 3-arylpropyl 2-azetidinones as cholesterol absorption inhibitors: Application of the palladium-catalyzed arylation of alkenes and alkynes, TETRAHEDRON, 56(31), 2000, pp. 5735-5742
Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663
Authors: van Heek, M Farley, C Compton, DS Hoos, L Alton, KB Sybertz, EJ Davis, HR
Citation: M. Van Heek et al., Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663, BR J PHARM, 129(8), 2000, pp. 1748-1754
Risultati: 1-9 |